Negative Costimulatory Pathways in Rejection & Tolerance

排斥反应中的负性共刺激途径

基本信息

批准号：
7263396
负责人：
NADER NAJAFIAN
金额：
$ 11.91万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-06-01 至 2010-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7263396
关键词：
Acute Address Adverse effects Alloantigen Allogenic Allograft Tolerance Allografting Animal Model Animals Antigens Apoptosis Autoimmune Responses Autoimmunity Binding Biological Assay Biological Models Blocking Antibodies CD28 gene CD80 gene CD8B1 gene CTLA4 gene Cardiac Cell Death Cell physiology Cells Chimeric Proteins Chronic Class Clonal Expansion Collaborations Colon Compatible Complement Complex Condition Cytokine Activation Data Development Disease Down-Regulation Educational Curriculum Environment Experimental Models Failure Family Frequencies Future Gene Chips Gene Targeting Generations Genes Genus Cola Goals Graft Rejection Graft Survival Heart Heart Transplantation Homologous Gene Human Immune Immune response Immunology Immunosuppression Immunotherapy In Vitro Inbred BALB C Mice Inflammation Inflammatory Islets of Langerhans Transplantation Kidney Knockout Mice Knowledge Laboratories Lead Life Ligands Lymphoid Lymphoid Tissue MHC Class II Genes Malignant Neoplasms Mediating Mediator of activation protein Memory Mentored Clinical Scientist Development Award (K08)Mentors Microarray Analysis Modeling Molecular Profiling Monoclonal Antibodies Morphology Mus Numbers Opportunistic Infections Organ Organ Transplantation Paper Pathway interactions Peptides Pharmaceutical Preparations Phase Phenotype Physiological Play Positioning Attribute Primates Principal Investigator Process Production Protein Family Protocols documentation Rate Regulation Reporting Research Personnel Rodent Model Role Signal Pathway Signal Transduction Site Skin Skin Transplantation Solid Specificity Survival Rate T memory cell T-Cell Activation T-Lymphocyte Testing Testis Therapeutic Therapeutic immunosuppression Tissues Transgenic Mice Transgenic Organisms Transplantation Transplantation Tolerance Withdrawal anergy base cell mediated immune response chemokine clinically relevant cytokine design desire expression cloning graft failure heart allograft immune function immunoregulation in vivo isoimmunity knockout animal knockout gene member mouse model novel novel strategies prevent programs receptor research study response size skin allograft tool

项目摘要

DESCRIPTION (provided by applicant): The aim of my proposal is to examine the in vivo functions and the mechanisms of action of novel inhibitory costimulatory molecules PD-PDL and B7-H3 in allograft rejection with the goal of harnessing their function to achieve allograft tolerance. This topic has great clinical relevance for transplantation in general as blockade of conventional positive T cell costimulatory pathway such as B7-CD28 has not been effective in reproducibly inducing tolerance in stringent murine transplant models as well as in larger animals such as primates. An important theme of my proposal is that harnessing physiologic mechanisms of regulation by novel negative T cell costimulatory pathways in addition to positive T cell costimulatory blockade are critical to achieve tolerance in humans. I have generated extensive data about the role of negative costimulatory pathways CTLA4-B7 and PD-1/PDL in CD4 and CDS mediated alloimmune responses in vivo. I also have promising preliminary data about the role of the recently described member of CD28 family, B7-H3 in a vascularized cardiac model. I plan to extend these studies using a number of unique tools that will enable me to dissect the functions, mechanisms and interactions of negative and positive costimulatory pathways in regulating alloimmune responses in vivo. These include well established animal models, novel gene knockout animals targeting specific costimulatory molecules, agents to target novel costimulatory pathways and finally elegant models of CD8+ and CD4+ TCR transgenic mice that allow tracking of alloreactive T cell responses in vivo. The Mentored Clinical Scientist Development Award will provide me with the critical opportunity to further expand my knowledge in immunology necessary for achieving independence. My mentor's and co-mentor's laboratories provide an ideal environment to accomplish the aims of my project because of their strong background in transplantation immonology, their collaborative momentum and their exemplary didactic and ethical curricula.

描述（由申请人提供）：我的提议的目的是检查体内功能和新型抑制性共刺激分子PD-PDL和B7-H3在同种异体移植拒绝中的作用机理，以利用其功能来实现同种异体移植力的目标。该主题一般来说，对于传统的阳性T细胞共刺激途径（例如B7-CD28）的封锁而言，该主题具有很大的临床相关性，在严格的鼠类移植模型以及较大的动物（如灵长类动物）中，诸如B7-CD28等常规阳性T细胞的封闭途径尚未有效。我的提议的一个重要主题是，除了阳性T细胞共刺激性阻滞外，还要利用新型的T细胞共刺激途径来利用生理机制，这对于实现人类的耐受性至关重要。我已经生成了有关CTLA4-B7和PD-1/PDL负面刺激途径在CD4中的作用的广泛数据，并且CDS介导的体内介导的同种免疫反应。关于最近描述的CD28家族成员B7-H3在血管化心脏模型中的作用，我还拥有有希望的初步数据。我计划使用许多独特的工具扩展这些研究，使我能够在调节体内调节同种异体免疫反应时剖析负和阳性共刺激途径的功能，机制和相互作用。这些包括良好的动物模型，针对特定共刺激分子的新型基因敲除动物，针对新型的刺激途径的药物，最后是CD8+和CD4+ TCR转基因小鼠的优雅模型，允许在体内跟踪同种反应性T细胞反应。指导的临床科学家发展奖将为我提供至关重要的机会，以进一步扩大我在实现独立性所必需的免疫学方面的知识。我的导师和同事的实验室提供了一个理想的环境来实现我的项目目标，因为它们在移植侵犯，协作势头和典范的教学课程和道德课程方面具有强大的背景。